C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/46 (2006.01) A61P 11/06 (2006.01) C07H 21/04 (2006.01) C07K 14/47 (2006.01) C12N 9/22 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2407865
The present invention relates to novel eosinophil cationic proteins characterised by the presence of a single nucleotide polymorphism. The presence of such polymorphism has been correlated to an advantageous phenotype being a reduced disposition to allergic and asthmatic disorders.
L'invention concerne des nouvelles protéines cationiques éosinophiles, caractérisées par la présence d'un polymorphisme d'un nucléotide. La présence d'un tel polymorphisme a été corrélée à un phénotype avantageux qui possède une disposition moindre aux troubles allergiques et asthmatiques.
Bystrom Jonas
Hogbom Erik
Jonsson Ulla-Britt
Venge Per
Gowling Lafleur Henderson Llp
Innoventus Project Ab
LandOfFree
Novel eosinophil cationic proteins used in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel eosinophil cationic proteins used in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel eosinophil cationic proteins used in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1933878